Journal ArticleOPEN ACCESS

Interleukin-6 gene amplification and shortened survival in glioblastoma patients

British Journal of Cancer (2007) 96(3) 474-476
DOI: 10.1038/sj.bjc.6603586
116Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interleukin-6 (IL-6) is known to promote tumour growth and survival. We evaluated IL-6 gene amplification in tumours from 53 glioma patients using fluorescence in situ hybridisation. Amplification events were detected only in glioblastomas (15 out of 36 cases), the most malignant tumours, and were significantly associated with decreased patient survival. © 2007 Cancer Research.

Author supplied keywords

Cite

CITATION STYLE

APA

Tchirkov, A., Khalil, T., Chautard, E., Mokhtari, K., Véronèse, L., Irthum, B., … Verrelle, P. (2007). Interleukin-6 gene amplification and shortened survival in glioblastoma patients. British Journal of Cancer, 96(3), 474–476. https://doi.org/10.1038/sj.bjc.6603586

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free